| Literature DB >> 29937753 |
Xiangfeng Qin1, Yaqian Xiao1, Cheng Ye1, Jingyi Jia1, Xiangjiang Liu1, Hongwei Liang2, Guiwei Zou2, Guangfu Hu1.
Abstract
17β-estradiol (E2) is an important sex steroid produced by ovary and brain. In mammals, E2 plays an important role in hypothalamus-pituitary-gonad axis to regulate puberty onset, however, little is known about the functional role of E2 in teleost pituitary. Using prepubertal grass carp as model, three nuclear estrogen receptors (nERs: estrogen receptor alpha, estrogen receptor beta 1, and estrogen receptor beta 2) and two G protein-coupled estrogen receptors (GPER1: GPER1a and GPER1b) were isolated from grass carp pituitary. Tissue distribution analysis indicated that both nERs and GPERs were highly detected in grass carp pituitary, which suggested that E2 should play an important role in grass carp pituitary. Using primary cultured grass carp pituitary cells as model, high-throughput RNA-seq was used to examine the E2-induced differentially expressed genes (DEGs). Transcriptomic analysis showed that E2 could significantly upregulate the expression of 28 genes in grass carp pituitary cells, which were characterized into different functions including reproduction, gonad development, and central nervous system development. Further studies confirmed that E2 could induce luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion and mRNA expression in prepubertal grass carp pituitary in vivo and in vitro. In the pituitary, LH and FSH regulation by E2 were mediated by both ERβ and GPER1. Apparently, E2-induced LHβ and FSHβ mRNA expression were mediated by adenylyl cyclase/cAMP/protein kinase A, phospholipase C/inositol 1,4,5-triphosphate/protein kinase C, and Ca2+/calmodulin/CaM-dependent protein kinase II pathways. In addition to LH and FSH, E2 could also induce growth regulation by estrogen in breast cancer 1 (a novel regulator for pituitary development) mRNA expression in grass carp pituitary cells. These results, as a whole, suggested that E2 could play an important role in gonadotropin hormone release and pituitary development in prepubertal grass carp.Entities:
Keywords: E2; follicle-stimulating hormone; grass carp; growth regulation by estrogen in breast cancer 1; luteinizing hormone; pituitary
Year: 2018 PMID: 29937753 PMCID: PMC6002485 DOI: 10.3389/fendo.2018.00308
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Phylogenetic analysis and tissue distribution of ERs and protein-coupled estrogen receptors (GPERs) in grass carp. (A) Phylogenetic analysis of ER amino acid sequences in vertebrate species using neighbor-joining method with MEGA6.0. The Oryzias latipes AR was used as the outgroup. (B) Phylogenetic tree of grass carp GPER using predicted amino acid sequences using neighbor-joining method with MEGA6.0 program. NK3R from grass carp served as an outgroup to root the tree. (C) Tissue distribution of estrogen receptor alpha (ERα), estrogen receptor beta 1 (ERβ1), estrogen receptor beta 2 (ERβ2), GPER1a, and GPER1b in grass carp brain areas. Total RNA was isolated from brain areas in grass carp and subjected to reverse transcription PCR (RT-PCR) using primers specific for carp ERα, ERβ1, ERβ2, GPER1a, and GPER1b transcripts, respectively. Parallel RT-PCR for β-actin was also conducted to serve as the internal control.
Genes upregulated by E2 in prepubertal grass carp pituitary cells.
| Gene | Description | Fold change | GO-biological process |
|---|---|---|---|
| Derlin-3 | 10.21 | Degradate misfolded glycoproteins | |
| Peptide- | 3.86 | Degradate misfolded glycoproteins | |
| Luteinizing hormone beta subunit | 5.19 | Reproduction | |
| Follicle-stimulating hormone beta subunit | 1.82 | Reproduction | |
| Dopamine D2 receptor (GPCR) | 1.79 | Reproduction | |
| Growth regulation by estrogen in breast cancer 1 | 5.78 | Estrogen receptor binding | |
| E3 ubiquitin-protein ligase RNF4 | 1.73 | Estrogen receptor binding | |
| Progesterone receptor 1 | 1.71 | Steroid binding | |
| Apolipoprotein C Ia | 2.25 | Cholesterol metabolic process | |
| Nuclear protein 1 | 2.23 | Male gonad development | |
| Nuclear receptor subfamily 5 group A (SF-1) | 2.34 | Male gonad development | |
| Dynein regulatory complex subunit 7 | 1.68 | Spermatogenesis | |
| Proteolipid protein 1b | 6.3 | Central nervous system development | |
| Hyaluronan and proteoglycan link protein 3 | 4.43 | Central nervous system development | |
| Neuropilin-1a isoform 1 precursor | 1.83 | Central nervous system development | |
| S100 calcium binding protein, beta (neural) | 2.1 | Central nervous system development | |
| Leucine-rich repeat-containing protein 4 | 2.08 | Synaptic adhesion protein | |
| Synaptotagmin-13 precursor | 2.19 | Synaptic vesicle transport | |
| Occludin-like | 2.03 | Cell–cell junction organization | |
| Fibrillin-1-like | 2.61 | Cell proliferation | |
| Plasminogen activator PLAU | 3.19 | Cell proliferation | |
| Fibroblast growth factor receptor 4 | 1.63 | Cell proliferation | |
| Hyaluronidase-2-like | 1.71 | Cellular response to FGF stimulus | |
| Lysosomal thioesterase PPT2-like | 1.61 | Fatty-acyl-CoA biosynthetic process | |
| tRNA (cytosine-5-)-methyltransferase | 1.77 | Methyltransferase | |
| Transmembrane protein 53 | 1.81 | Integral component of membrane | |
| Family with sequence similarity 222, member A | 1.73 | Protein dimerization activity | |
| Transmembrane and TPR repeat-containing protein 2 | 1.67 | Calcium ion homeostasis |
Genes downregulated by E2 in prepubertal grass carp pituitary cells.
| Name | Description | Fold change | GO-molecular function |
|---|---|---|---|
| Ryanodine receptor 3 | 0.39 | Calcium ion binding | |
| Membrane calcium-transporting ATPase 2 | 0.56 | Calcium-transporting | |
| Cadherin EGF LAG seven-pass G-type receptor 1 | 0.54 | Calcium ion binding | |
| Low-density lipoprotein receptor-like | 0.60 | Calcium ion binding | |
| Granulin | 0.50 | Response to estradiol | |
| 24-dehydrocholesterol reductase | 0.60 | Steroid metabolic process | |
| Lanosterol synthase | 0.60 | Steroid biosynthetic process | |
| Sterol-4-alpha-carboxylate 3-dehydrogenase | 0.59 | Steroid dehydrogenase activity | |
| Protein scribble homolog isoform X8 | 0.59 | GTPase activator activity | |
| Small G protein signaling modulator 1 | 0.52 | GTPase activator activity | |
| Protein FAM13A isoform X2 | 0.55 | GTPase activator activity | |
| Secreted frizzled-related protein 2 | 0.56 | Wnt-protein binding | |
| Catenin beta-1-like | 0.56 | Wnt signaling pathway | |
| CD2-associated protein | 0.57 | Beta-catenin binding | |
| NFX1-type zinc finger-containing protein 1-like | 0.59 | Transcription factor activity | |
| TSC22 domain family protein 3 | 0.59 | Transcription factor activity | |
| Metalloproteinase inhibitor 3-like | 0.58 | Metalloendopeptidase inhibitor | |
| Tissue inhibitor of metalloproteinase 2 | 0.59 | Metalloendopeptidase inhibitor | |
| Bromodomain-containing protein 4 | 0.59 | NF-kappa B signaling | |
| c-Jun-amino-terminal kinase-interacting protein | 0.58 | JNK/MAPK cascade | |
| PH-interacting protein isoform X2 | 0.60 | Insulin receptor binding | |
| Cysteine rich transmembrane BMP regulator 1 | 0.58 | IGF binding | |
| IGF-I receptor subtype a | 0.58 | IGF binding | |
| Collagen alpha-1 (V) chain | 0.59 | Heparin/integrin binding | |
| Receptor-type tyrosine-protein phosphatase F | 0.58 | Heparin binding | |
| Neuron navigator 2 isoform X1 | 0.58 | Heparin binding | |
| Ankyrin-2-like | 0.59 | ATPase binding | |
| ATP-binding cassette sub-family A member 3 | 0.55 | ATPase activity | |
| Rap guanine nucleotide exchange factor 2 | 0.60 | Adrenergic receptor binding | |
| Fn1 protein | 0.56 | Adrenal gland development | |
| T-box transcription factor TBX20 | 0.53 | DNA binding | |
| MHC class II regulatory factor RFX1 | 0.43 | DNA binding | |
| Adenosine deaminase, RNA-specific, B1 | 0.58 | RNA binding | |
| Family with sequence similarity 120C | 0.60 | RNA binding | |
| Somatostatin receptor type 3 | 0.60 | Neuropeptide binding | |
| Microtubule-associated protein 1A-like | 0.59 | Ubiquitin protein ligase binding |
Figure 2E2 induce luteinizing hormone (LH) secretion and mRNA expression in grass carp pituitary cells. (A) In the time-course experiment, pituitary cells were incubated with E2 (10 nM) for the duration as indicated. (B) In parallel studies for dose dependence, pituitary cells were challenged for 24 h with increasing levels of E2 (1–1,000 nM). (C) Effects of E2 (10 nM), sGnRH (1 µM), and cGnRH (1 µM) on LH and follicle-stimulating hormone (FSH) mRNA expression in grass carp pituitary cells. After drug treatment, culture medium was harvested for measurement of LH secretion, and the remaining cells were used for total RNA preparation for real-time PCR of the LHβ and FSHβ mRNA. Data presented are expressed as mean ± SEM, and groups denoted by different letters represent a significant difference at P < 0.05 (ANOVA followed by a Dunnett’s test).
Figure 3E2 induce follicle-stimulating hormone (FSH)β and growth regulation by estrogen in breast cancer 1 (GREB1) mRNA expression in grass carp pituitary cells. (A) In the time-course experiment, pituitary cells were incubated with E2 (100 nM) for the duration as indicated. (B) In parallel studies for dose dependence, pituitary cells were challenged for 24 h with increasing levels of E2 (1–1,000 nM). After drug treatment, the remaining cells were used for total RNA preparation for real-time PCR of the FSHβ and GREB1 mRNA expression. Data presented are expressed as mean ± SEM, and groups denoted by different letters represent a significant difference at P < 0.05 (ANOVA followed by a Dunnett’s test).
Figure 4Receptor specificity of E2-induced luteinizing hormone (LH) secretion and mRNA expression. (A) Effects of ER agonists on LH transcript expression and hormone secretion. For LHβ mRNA expression, pituitary cells were treated for 24 h with E2 (10 nM), G protein-coupled estrogen receptor (GPER) agonist G-1 (1 µM), estrogen receptor alpha agonist propylpyrazole triol (PPT) (1 µM), and ERβ agonist DPN (1 µM), respectively. (B) Effects of GPER antagonist G-15 and ER antagonist ICI182780 on E2-induced LHβ secretion and mRNA expression. Pituitary cells were treated for 24 h with E2 (10 nM) in the presence or absence of the G-15 (10 µM) or ICI182780 (10 µM), respectively. (C) Effects of GPER antagonist G-15 or ER antagonist ICI182780 on G-1- or DPN-induced LH secretion and mRNA expression. Grass carp pituitary cells were incubated for 24 h with GPER agonist G1 (1 µM) in the presence or absence of G-15 (10 µM), or ERβ agonist DPN (1 µM) in the presence or absence of ICI182780 (10 µM).
Figure 5Receptor specificity of E2-induced follicle-stimulating hormone (FSH)β and growth regulation by estrogen in breast cancer 1 (GREB1) mRNA expression. (A) Effects of ER agonists on FSHβ and GREB1 mRNA expression. Pituitary cells were treated for 24 h with E2 (10 nM), G protein-coupled estrogen receptor (GPER) agonist G-1 (1 µM), estrogen receptor alpha agonist propylpyrazole triol (PPT) (1 µM), and ERβ agonist DPN (1 µM), respectively. (B) Effects of GPER antagonist G-15 and ER antagonist ICI182780 on E2-induced FSHβ and GREB1 mRNA expression. Pituitary cells were treated for 24 h with E2 (10 nM) in the presence or absence of the G-15 (10 µM) or ICI182780 (10 µM), respectively. (C) Effects of GPER antagonist G-15 or ER antagonist ICI182780 on G-1- or DPN-induced FSHβ or GREB1 mRNA expression. Grass carp pituitary cells were incubated for 24 h with GPER agonist G1 (1 µM) in the presence or absence of G-15 (10 µM), or ERβ agonist DPN (1 µM) in the presence or absence of ICI182780 (10 µM).
Figure 6E2-induced luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion and mRNA expression in grass carp. (A) In vivo effects of E2 on LHβ and FSHβ mRNA expression in grass carp pituitary. (B) E2-induced serum LH secretion in prepuberty grass carp. (C) Effect of E2 on FSH secretion in the serum of prepuberty grass carp. The quantified graph is shown below the representative blots in each group. Data presented are expressed as mean ± SEM (n = 3). (D) Receptor specificity of E2-induced FSH synthesis in grass carp pituitary cells. The quantified graph is shown below the representative blots in each group. Data presented are expressed as mean ± SEM (n = 3).
Figure 7Signal transduction of E2-induced luteinizing hormone (LH)β and follicle-stimulating hormone (FSH)β mRNA expression in grass carp pituitary cells. (A) Effects of 24-h co-treatment with the adenylyl cyclase inhibitor MDL12330A (20 µM) or protein kinase A inhibitor (20 µM) on E2 (10 nM)-induced LHβ and FSHβ mRNA expression. (B) Effects of 24-h co-treatment with the phospholipase C inhibitor U73122 (10 µM) or protein kinase C inhibitor GF109203X (20 µM) on E2 (10 nM)-induced LHβ and FSHβ mRNA expression in carp pituitary cells. (C) Effects of 24-h co-treatment with inositol 1,4,5-triphosphate receptor blocker 2-APB (100 µM) or VSCC blocker Nifedipine (10 µM) on E2 (10 nM)-induced LHβ and FSHβ mRNA expression. (D) Effects of 24-h co-treatment with calmodulin antagonist calmidazolium (1 µM) or CaM-dependent protein kinase II inactivator KN62 (10 µM), respectively, on E2 (10 nM)-induced LHβ and FSHβ mRNA expression in grass carp pituitary cells.
Figure 8Working model of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) regulation by E2 in grass carp pituitary cells. In grass carp pituitary cells, E2 could activate both protein-coupled estrogen receptor (GPER) and ER to induce LH and FSH secretion and synthesis. These effects appear to be mediated through the adenylyl cyclase/cAMP/protein kinase A, phospholipase C (PLC)/inositol 1,4,5-triphosphate/protein kinase C (PKC), and Ca2+/calmodulin/CaM-dependent protein kinase II (CaMK-II) cascades.